Europeans throw away over 88 million tons of food every year. A new Estonian project wants every gram of it to be used to manufacture bioplastics and eco-friendly cosmetics
The University of Amsterdam (UvA)’s Faculty of Science, UvA Ventures Holding B.V. and Innovation Exchange Amsterdam (IXA-UvA) are pooling their resources to fund Macrobian Biotech BV, a single asset biotech company that will further develop medicine for the treatment of Parkinson’s disease.
In a show of faith in European biomedical research, the pharma company is extending its open innovation approach and setting up a bioincubator at its campus in Beerse, Belgium. Start-ups using the facility will have access to expertise, equipment and funding
Growth in the marine sector is welcome, but needs to be sensitively managed; we shouldn’t put wind turbines in fishing grounds. Investing in seabed mapping technology will ensure resources are used in a sustainable way, says Maria do Céu Patrão Neves, MEP
It’s a virtuous circle: New approval processes put in place by the European Medicines Agency are de-risking drug development, promoting investment in early-stage biotech and meeting unmet medical needs, says Paul Morton
The EU must take action to translate expertise in key underpinning technologies such as biotechnology, photonics and nanotechnology into industry-powered growth, says EU Commissioner Antonio Tajani
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.